Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

411 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Review of β-carboline and its derivatives as selective MAO-A inhibitors.
Benny F, Kumar S, Jayan J, Abdelgawad MA, Ghoneim MM, Kumar A, Manoharan A, Susan R, Sudevan ST, Mathew B. Benny F, et al. Among authors: manoharan a. Arch Pharm (Weinheim). 2023 Jul;356(7):e2300091. doi: 10.1002/ardp.202300091. Epub 2023 Apr 6. Arch Pharm (Weinheim). 2023. PMID: 37021551 Review.
Discerning of isatin-based monoamine oxidase (MAO) inhibitors for neurodegenerative disorders by exploiting 2D, 3D-QSAR modelling and molecular dynamics simulation.
Kumar S, Jayan J, Manoharan A, Benny F, Abdelgawad MA, Ghoneim MM, El-Sherbiny M, Thazhathuveedu Sudevan S, Aneesh TP, Mathew B. Kumar S, et al. Among authors: manoharan a. J Biomol Struct Dyn. 2024 Mar;42(5):2328-2340. doi: 10.1080/07391102.2023.2214216. Epub 2023 Jun 1. J Biomol Struct Dyn. 2024. PMID: 37261844
Assembling a Cinnamyl Pharmacophore in the C3-Position of Substituted Isatins via Microwave-Assisted Synthesis: Development of a New Class of Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson's Disease.
Manoharan A, Oh JM, Benny F, Kumar S, Abdelgawad MA, Ghoneim MM, Shaker ME, El-Sherbiny M, Almohaimeed HM, Gahtori P, Kim H, Mathew B. Manoharan A, et al. Molecules. 2023 Aug 21;28(16):6167. doi: 10.3390/molecules28166167. Molecules. 2023. PMID: 37630420 Free PMC article.
Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation.
Kumar S, Manoharan A, J J, Abdelgawad MA, Mahdi WA, Alshehri S, Ghoneim MM, Pappachen LK, Zachariah SM, Aneesh TP, Mathew B. Kumar S, et al. Among authors: manoharan a. RSC Adv. 2023 Mar 23;13(14):9513-9529. doi: 10.1039/d3ra00526g. eCollection 2023 Mar 20. RSC Adv. 2023. PMID: 36968055 Free PMC article.
Correction: Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation.
Kumar S, Manoharan A, J J, Abdelgawad MA, Mahdi WA, Alshehri S, Ghoneim MM, Pappachen LK, Zachariah SM, Aneesh TP, Mathew B. Kumar S, et al. Among authors: manoharan a. RSC Adv. 2023 Apr 6;13(16):10956. doi: 10.1039/d3ra90030d. eCollection 2023 Apr 3. RSC Adv. 2023. PMID: 37033440 Free PMC article.
Impact of Phlebotomy on Quality of Life in Low-Risk Polycythemia Vera.
Visweshwar N, Fletcher B, Jaglal M, Laber DA, Patel A, Eatrides J, Rathnakumar GR, Iyer KV, Ayala I, Manoharan A. Visweshwar N, et al. Among authors: manoharan a. J Clin Med. 2024 Aug 22;13(16):4952. doi: 10.3390/jcm13164952. J Clin Med. 2024. PMID: 39201091 Free PMC article. Review.
411 results